We address whether T cell responses induced by different vaccine platforms (mRNA-1273, BNT162b2, Ad26.COV2.S, NVX-CoV2373) cross-recognize early SARS-CoV-2 variants. T cell responses to early variants were preserved across vaccine platforms. By contrast, significant overall decreases were observed for memory B cells and neutralizing antibodies. In subjects ∼6 months post-vaccination, 90% (CD4
+
) and 87% (CD8
+
) of memory T cell responses were preserved against variants on average by AIM assay, and 84% (CD4
+
) and 85% (CD8
+
) preserved against Omicron. Omicron RBD memory B cell recognition was substantially reduced to 42% compared to other variants. T cell epitope repertoire analysis revealed a median of 11 and 10 spike epitopes recognized by CD4
+
and CD8
+
T cells, with average preservation > 80% for Omicron. Functional preservation of the majority of T cell responses may play an important role as second-level defenses against diverse variants.
Highlights d T cell responses recognize at least 30-40 epitopes in each donor d Immunodominance is correlated with HLA binding d Immunodominant regions for CD4 + T cells have minimal overlap with antibody epitopes d CD8 + T cell responses depend on the repertoire of HLA class I alleles
Highlights d T cells of exposed donors or vaccinees effectively recognize SARS-CoV-2 variants d Effective recognition in AIM and FluoroSPOT assays, for spike and other proteins d 93% and 97% of CD4 and CD8 epitopes are 100% conserved across variants
The emergence of SARS-CoV-2 variants highlighted the need to better
understand adaptive immune responses to this virus. It is important to address
whether also CD4+ and CD8+ T cell responses are affected, because of the role
they play in disease resolution and modulation of COVID-19 disease severity.
Here we performed a comprehensive analysis of SARS-CoV-2-specific CD4+ and CD8+
T cell responses from COVID-19 convalescent subjects recognizing the ancestral
strain, compared to variant lineages B.1.1.7, B.1.351, P.1, and CAL.20C as well
as recipients of the Moderna (mRNA-1273) or Pfizer/BioNTech (BNT162b2) COVID-19
vaccines. Similarly, we demonstrate that the sequences of the vast majority of
SARS-CoV-2 T cell epitopes are not affected by the mutations found in the
variants analyzed. Overall, the results demonstrate that CD4+ and CD8+ T cell
responses in convalescent COVID-19 subjects or COVID-19 mRNA vaccinees are not
substantially affected by mutations found in the SARS-CoV-2 variants.
SUMMARYT cells are involved in control of SARS-CoV-2 infection. To establish the patterns of immunodominance of different SARS-CoV-2 antigens, and precisely measure virus-specific CD4+ and CD8+ T cells, we studied epitope-specific T cell responses of approximately 100 convalescent COVID-19 cases. The SARS-CoV-2 proteome was probed using 1,925 peptides spanning the entire genome, ensuring an unbiased coverage of HLA alleles for class II responses. For HLA class I, we studied an additional 5,600 predicted binding epitopes for 28 prominent HLA class I alleles, accounting for wide global coverage. We identified several hundred HLA-restricted SARS-CoV-2-derived epitopes. Distinct patterns of immunodominance were observed, which differed for CD4+ T cells, CD8+ T cells, and antibodies. The class I and class II epitopes were combined into new epitope megapools to facilitate identification and quantification of SARS-CoV-2-specific CD4+ and CD8+ T cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.